ABVC BioPharma, Inc.
ABVCHealthcare|Biotechnology|US
$0.97
-0.00 (-0.25%)
Tangible Book / Share
$0.47
Cash / Share
$0.00
Clinical Trials (2)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT05202327 PDC-1421 Treatment in Adult Patients With ADHD | Attention-Deficit Hyperactivity Disorder (ADHD) | P2 | Completed | 99 | RCT, Double-blind | PDC-1421 Capsule, Placebo |
| NCT05414747 Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE) | Retinal Detachment | N/A | SUSPENDED | 40 | RCT, Open-label | — |